Navigation Links
BD Rx Announces FDA Approval of High-Demand Injectable for Pain Management
Date:11/4/2013

opine-like action and, therefore should be used with caution in patients with a history of bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease or hypertension and in patients with lower respiratory disease including asthma.

It has additive effects with alcohol and other CNS depressants. MAO inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines.
The most frequent adverse reactions are: Nervous System: sedation, sleepiness, dizziness, disturbed coordination; GI System: epigastric distress; and Respiratory System: thickening of bronchial secretions

Please see diphenhydramine full prescribing information for additional important safety information.

About Metoclopramide Injection, USP
INDICATIONS AND USAGE

Metoclopramide Injection, USP is indicated for:

  • the relief of symptoms associated with acute and recurrent diabetic gastric stasis
  • prophylaxis of vomiting associated with emetogenic cancer chemotherapy
  • the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable.

Metoclopramide Injection, USP also may be used to:

  • facilitate small bowel intubation in adults and pediatric patients in whom the tube does not pass the pylorus with conventional maneuvers
  • stimulate gastric emptying and intestinal transit of barium in cases where delayed emptying interferes with radiological examination of the stomach and/or small intestine.

IMPORTANT SAFETY INFORMATION

  • Metoclopramide treatment can cause tardive dyskinesia, a serious movement disorder that is often irreversible. Therapy should be discontinued in pati
    '/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. WuXi PharmaTech Announces Licensing Agreement for Patient-Derived Xenograft Models with Mayo Clinics Center for Individualized Medicine
2. VG Life Sciences, Inc. Announces the Initiation of IND-Enabling Animal Safety Studies
3. ISPE Announces Plans for Its Drug Shortages Initiative through 2014
4. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
5. IGI Laboratories, Inc. Announces Thirteenth ANDA Submission
6. Pharmagen Announces Shift In Growth Strategy
7. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2014 And Announces ARRY-520 Development Strategy
8. MSA Announces Fourth Quarter Dividend
9. Sorrento Therapeutics Announces Closing of Public Offering of Common Stock
10. Veracyte, Inc. Announces Pricing of Initial Public Offering
11. iHealth Announces Availability of Wireless Smart-Gluco Monitoring System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... CHICAGO , July 31, 2015 ... a press release on July 28, 2015, "Surviving ... Safety Launches Fundraising for Patient Safety." ... last sentence should read: "PPAHS is ... of Patients on Opioids. For more information on the ...
(Date:7/31/2015)... WAYNE, Pa. , July 31, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced the closing of its previously announced underwritten ... stock at a public offering price of $11.25 ... the offering included 1,000,000 shares issued upon the ...
(Date:7/31/2015)... 31, 2015 Magnaquest, a ... data and cloud computing operators has signed a ... giant for Internet of Things (IoT) related initiative. ... on subscription model.      (Logo: ... striving for business innovations to make healthcare services ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... Oct. 26 Palomar Pomerado Health (PPH), a Magnet® ... has been selected by San Diego-based CareFusion, a global ... latest Pyxis technologies that focus on improving the safety ... partner in innovation with CareFusion, PPH physicians, nurses, pharmacists, ...
... Oct. 26 Nautilus Neurosciences, Inc., a neurology-focused specialty ... pivotal safety and efficacy studies of CAMBIA™ (diclofenac potassium ... World Congress on Controversies in Neurology Conference (CONy) in ... presented in a poster (#23) entitled, "Rapid and Sustained ...
Cached Medicine Technology:CareFusion Selects Palomar Pomerado Health as Development Partner for Patient Safety Technologies 2CareFusion Selects Palomar Pomerado Health as Development Partner for Patient Safety Technologies 3New Analysis of CAMBIA™ Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology 2New Analysis of CAMBIA™ Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology 3New Analysis of CAMBIA™ Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology 4
(Date:7/31/2015)... ... 31, 2015 , ... Jacksonville-based drug and alcohol rehabilitation center, ... Center. The medical community, social workers, law enforcement, and government officials are all ... the effort to better understand and combat sex trafficking. Lead by sex trafficking ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a ... Those looking to catch a new and refreshing show on Broadway, look no further ... achievements including an Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille Lortel ...
(Date:7/31/2015)... New York (PRWEB) , ... ... ... trial attorney Jason T. Brown’s live lecture on pharmaceutical negligence is now ... 28th, 2015 was well received with a 94% approval rating from the ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Transfinder, a software ... , Total sales were up 16 percent year-over-year for the first six months ended ... Civitella said he expected Transfinder to beat last year’s record-revenue mark of $10.4 million. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Mullin/Ashley Associates , ... the 2015 Aster Awards national competition for a marketing communications campaign created for ... surrounding communities in Coastal Maryland and Southern Delaware. , A Bronze Award was ...
Breaking Medicine News(10 mins):Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Mullin/Ashley Associates Wins in the 2015 Aster Awards National Competition for Excellence in Medical Marketing 2
... new test that screens babies for the presence of a ... on Tuesday. Group B streptococcus// is a common infection that ... pneumonia, meningitis, neurological damage or even death. ,Although ... current screening methods can leave some babies at risk for ...
... the mind are really mysterious, however these have inspired ... of the brain affected by the// personality disorder schizophrenia. ... into a tool that can help diagnose the condition. ... of people with schizophrenia is yet to be pinned ...
... medication have long been the cornerstones of managing type ... benefits// these patients. ,Now, a new systematic ... levels, increases the body’s sensitivity to insulin, and decreases ... fat. ,“Type 2 diabetes is an increasing ...
... by Satish K. Pillai, PhD, a staff research associate at ... San Francisco it was found that HIV in the brain ... ,The patients suffered severe to moderate cognitive decline. ... a particular mutation in the HIV envelope gene. The study ...
... pilgrim died of respiratory problems while on a tour ... woman too succumbed// to high-altitude illness while pursuing the ... pilgrim sites in Asia is fast turning into a ... Devi Shriram Bhoyar, a 38-year-old god woman from Maharashtra, ...
... Sandip Datta and Joshua Fierer of the University of ... gamma radiation// killed bacteria are very effective in inducing ... ,The U.S. National Institute of Allergy and Infectious ... said that these bacterial cultures could be used as ...
Cached Medicine News:Health News:FDA Approves New Test For Screening Infection In Babies 2Health News:FDA Approves New Test For Screening Infection In Babies 3Health News:Diagnosing Schizophrenia 2Health News:Exercise in Itself Improves Blood Glucose Control in Type 2 Diabetes 2Health News:Exercise in Itself Improves Blood Glucose Control in Type 2 Diabetes 3Health News:Mutation in the Envelope Gene May Be the Reason for the Development of HIV Linked Cognitive Decline 2Health News:High-altitude Illness Affects Pilgrims of Mansarovar 2